IGF::OT::IGF SEER-LINKED VIRTUAL TISSUE REPOSITORY (VTR)

美国国家癌症研究所的监测，流行病学和最终结果（SEER）计划有兴趣开发一个SEER链接的虚拟组织库（VTR）。SEER VTR具有群体代表性和大样本框架，将成为收集强大生物标本的独特资源，即使是罕见肿瘤和结果。SEER人口统计学和临床数据可以通过自定义数据注释进行扩充，包括详细的化疗、复发时间和体重指数。 VTR试点研究的目的是评估SEER登记的能力 作为生物标本研究的资源 在病理学实验室中查找带有生物标本的病例，并确定检索这些生物标本的要求 提供指定数据项的自定义批注 VTR试点还将收取识别和注释这些生物标本的费用。

The National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Program is interested in developing a SEER-linked Virtual Tissue Repository (VTR). A SEER VTR, with its population representativeness and large sampling frame would be a unique resource for assembling robust collections of biospecimens even for rare tumors and outcomes. SEER demographic and clinical data can be augmented with custom annotation of data including detailed chemotherapy, time to recurrence, and body mass index. The objectives of the VTR Pilot Study are to assess the ability of SEER Registries To serve as a resource for biospecimen research To locate cases with biospecimens in pathology laboratories and determine the requirements to retrieve those biospecimens To provide custom annotation of specified data items The VTR Pilot will also capture costs to identify and annotate these biospecimens.